BBHVanEck Biotech ETF
Fund Description
VanEck Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS®US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
-
Fund Ticker
BBH -
Exchange
NASDAQ -
Inception Date
12/20/2011 -
ETF Structure
Physical -
Administrator
Van Eck Associates -
Custodian
State Street Bank and Trust Company -
Index Ticker
MVBBHTR -
Index Rebalancing
Quarterly
as of 05/27/22
-
30-Day SEC Yield
0.46% -
Total Net Assets
$454.5M -
Number of Holdings
25 -
Options
Available -
Gross Expense Ratio2
0.35% -
Net Expense Ratio/TER2
0.35% -
Distribution Frequency
Annual -
Next Distribution Date
12/16/2022
Portfolio Composition (%)
as of 05/26/22
- % of Net Assets
-
Stocks
100.00 -
Bonds
0.00 -
Other
0.00 -
Cash
0.00
Daily Holdings (%) as of 05/26/22 Daily Holdings
Total Holdings : 25
|
Ticker
|
Holding Name |
% of Net Assets |
Identifier (FIGI)
|
Shares
|
Asset Class |
Market Value (US$) |
|---|---|---|---|---|---|---|
|
AMGN US |
Amgen Inc | 15.11 |
BBG000BBS2Y0 |
262,022 |
Stock | 66,304,667 |
|
GILD US |
Gilead Sciences Inc | 7.95 |
BBG000CKGBP2 |
541,339 |
Stock | 34,900,125 |
|
VRTX US |
Vertex Pharmaceuticals Inc | 7.76 |
BBG000C1S2X2 |
126,312 |
Stock | 34,060,031 |
|
REGN US |
Regeneron Pharmaceuticals Inc | 7.18 |
BBG000C734W3 |
46,072 |
Stock | 31,487,448 |
|
MRNA US |
Moderna Inc | 6.67 |
BBG003PHHZT1 |
215,468 |
Stock | 29,260,554 |
|
IQV US |
Iqvia Holdings Inc | 4.94 |
BBG00333FYS2 |
104,356 |
Stock | 21,677,872 |
|
BNTX US |
Biontech Se | 4.90 |
BBG00Q70B3V1 |
135,908 |
Stock | 21,493,850 |
|
BIIB US |
Biogen Inc | 4.74 |
BBG000C17X76 |
101,786 |
Stock | 20,786,737 |
|
SGEN US |
Seagen Inc | 4.24 |
BBG000BH0FR6 |
134,349 |
Stock | 18,601,963 |
|
ILMN US |
Illumina Inc | 4.04 |
BBG000DSMS70 |
72,840 |
Stock | 17,741,639 |
|
TECH US |
Bio-Techne Corp | 3.97 |
BBG000C15114 |
47,713 |
Stock | 17,430,513 |
|
ICLR US |
Icon Plc | 3.21 |
BBG000CTSZQ6 |
64,747 |
Stock | 14,091,537 |
|
INCY US |
Incyte Corp | 3.04 |
BBG000BNPSQ9 |
175,712 |
Stock | 13,357,626 |
|
CRL US |
Charles River Laboratories Internationa | 3.01 |
BBG000BG5BL8 |
57,371 |
Stock | 13,207,378 |
|
ALNY US |
Alnylam Pharmaceuticals Inc | 2.89 |
BBG000BFGNJ5 |
101,050 |
Stock | 12,691,880 |
|
BMRN US |
Biomarin Pharmaceutical Inc | 2.83 |
BBG000CZWZ05 |
157,564 |
Stock | 12,425,497 |
|
BGNE US |
Beigene Ltd | 2.82 |
BBG00B6WF7T5 |
94,304 |
Stock | 12,378,343 |
|
QGEN US |
Qiagen Nv | 2.80 |
BBG000GTYWL7 |
268,957 |
Stock | 12,272,508 |
|
EXAS US |
Exact Sciences Corp | 2.09 |
BBG000CWL0F5 |
184,311 |
Stock | 9,189,746 |
|
CRSP US |
Crispr Therapeutics Ag | 1.16 |
BBG00DBBGRX1 |
92,377 |
Stock | 5,101,982 |
|
NVAX US |
Novavax Inc | 1.08 |
BBG000NVSBL7 |
100,936 |
Stock | 4,751,058 |
|
NTRA US |
Natera Inc | 1.02 |
BBG001J1BQ86 |
114,436 |
Stock | 4,476,736 |
|
GH US |
Guardant Health Inc | 0.86 |
BBG006D97VY9 |
98,315 |
Stock | 3,787,094 |
|
TXG US |
10x Genomics Inc | 0.86 |
BBG007WX14X0 |
79,880 |
Stock | 3,782,318 |
|
NTLA US |
Intellia Therapeutics Inc | 0.81 |
BBG007KC7PB0 |
79,044 |
Stock | 3,557,770 |
|
-- |
Other/Cash | 0.00 |
-- |
0 |
Cash | -12,539 |
← Scroll for more information →
These are not recommendations to buy or to sell any security. Securities and holdings may vary.